Journal articles on the topic 'Vinblastine, vincristine, vinca alkaloids'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Vinblastine, vincristine, vinca alkaloids.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Vishesh Verma, Shivam Sharma, Kritika Gaur, and Nitin Kumar. "Role of vinca alkaloids and their derivatives in cancer therapy." World Journal of Advanced Research and Reviews 16, no. 3 (December 30, 2022): 794–800. http://dx.doi.org/10.30574/wjarr.2022.16.3.1378.
Full textMontag, Gracia, Helga Stopper, Quoc Anh Ngo, and Henning Hintzsche. "The Biological Activity of the Novel Vinca Alkaloids 4-chlorochablastine and 4-chlorochacristine." Current Cancer Drug Targets 19, no. 3 (February 14, 2019): 222–30. http://dx.doi.org/10.2174/1568009618666180430142233.
Full textHuang, Yi, Yong Fang, Jinmin Wu, Jennifer M. Dziadyk, Xueming Zhu, Meihua Sui, and Weimin Fan. "Regulation of Vinca alkaloid-induced apoptosis by NF-κB/IκB pathway in human tumor cells." Molecular Cancer Therapeutics 3, no. 3 (March 1, 2004): 271–77. http://dx.doi.org/10.1158/1535-7163.271.3.3.
Full textNithyanandham Masilamani and Dhanraj Ganapathy. "Awareness of Vinca alkaloids among dental students." International Journal of Research in Pharmaceutical Sciences 11, SPL3 (September 18, 2020): 911–14. http://dx.doi.org/10.26452/ijrps.v11ispl3.3048.
Full textMayer, Szabolcs, Péter Keglevich, András Keglevich, and László Hazai. "New Anticancer Vinca Alkaloids in the Last Decade - A Mini-Review." Current Organic Chemistry 25, no. 10 (June 1, 2021): 1224–34. http://dx.doi.org/10.2174/1385272825666210216123256.
Full textSharma, Mukesh Kumar, Mohan Kumar, and Renu. "Biosynthesis and Modulation of Terpenoid Indole Alkaloids in Catharanthus roseus: A Review of Targeting Genes and Secondary Metabolites." Journal of Pure and Applied Microbiology 15, no. 4 (October 15, 2021): 1745–58. http://dx.doi.org/10.22207/jpam.15.4.05.
Full textNoble, Robert L. "The discovery of the vinca alkaloids—chemotherapeutic agents against cancer." Biochemistry and Cell Biology 68, no. 12 (December 1, 1990): 1344–51. http://dx.doi.org/10.1139/o90-197.
Full textAgrawal, Vaibhav, Diane T. Smelser, David J. Carey, Joseph J. Vadakara, and Sharif S. Khan. "Effect of the CEP72 Genotype and CYP3A5-Mediated Metabolism in Predicting Vincristine-Associated Peripheral Neuropathy." Blood 128, no. 22 (December 2, 2016): 5963. http://dx.doi.org/10.1182/blood.v128.22.5963.5963.
Full textKeglevich, András, Szabolcs Mayer, Réka Pápai, Áron Szigetvári, Zsuzsanna Sánta, Miklós Dékány, Csaba Szántay, Péter Keglevich, and László Hazai. "Attempted Synthesis of Vinca Alkaloids Condensed with Three-Membered Rings." Molecules 23, no. 10 (October 9, 2018): 2574. http://dx.doi.org/10.3390/molecules23102574.
Full textMayer, Szabolcs, András Keglevich, Csilla Sepsey Für, Hedvig Bölcskei, Viktor Ilkei, Péter Keglevich, and László Hazai. "Results in Chemistry of Natural Organic Compounds. Synthesis of New Anticancer Vinca Alkaloids and Flavone Alkaloids." Chemistry 2, no. 3 (August 10, 2020): 714–26. http://dx.doi.org/10.3390/chemistry2030046.
Full textNerkar, Amit Gajanan, Rushikesh P. Nagarkar, and Shubhangi Badar. "Ethnopharmacological review of vinca plant for anticancer activity." Current Trends in Pharmacy and Pharmaceutical Chemistry 4, no. 4 (November 15, 2022): 148–51. http://dx.doi.org/10.18231/j.ctppc.2022.026.
Full textLinh, Tran My, Nguyen Chi Mai, Pham Thi Hoe, Ninh Thi Ngoc, Phan Thi Hong Thao, Ninh Khac Ban, and Nguyen Tuong Van. "Development of a Cell Suspension Culture System for Promoting Alkaloid and Vinca Alkaloid Biosynthesis Using Endophytic Fungi Isolated from Local Catharanthus roseus." Plants 10, no. 4 (March 31, 2021): 672. http://dx.doi.org/10.3390/plants10040672.
Full textTembhe, Harshada, and Rupali Tasgaonkar. "Vinca Alkaloids – Anti cancer drugs." International Journal for Research in Applied Science and Engineering Technology 11, no. 1 (January 31, 2023): 408–16. http://dx.doi.org/10.22214/ijraset.2023.48559.
Full text-, Prabhavathi, and Anuradha Mal. "Nutraceutical properties of Vinca rosea." Biomedicine 42, no. 3 (July 3, 2022): 427–33. http://dx.doi.org/10.51248/.v42i3.1459.
Full textPandya, Prateek, Surendra P. Gupta, Kumud Pandav, Ritu Barthwal, B. Jayaram, and Surat Kumar. "DNA Binding Studies of Vinca Alkaloids: Experimental and Computational Evidence." Natural Product Communications 7, no. 3 (March 2012): 1934578X1200700. http://dx.doi.org/10.1177/1934578x1200700308.
Full textBurns, B. V., and J. C. Shotton. "Vocal fold palsy following vinca alkaloid treatment." Journal of Laryngology & Otology 112, no. 5 (May 1998): 485–87. http://dx.doi.org/10.1017/s002221510014085x.
Full textLobert, Sharon, Bojana Vulevic, and John J. Correia. "Interaction of Vinca Alkaloids with Tubulin: A Comparison of Vinblastine, Vincristine, and Vinorelbine†." Biochemistry 35, no. 21 (January 1996): 6806–14. http://dx.doi.org/10.1021/bi953037i.
Full textGout, Peter W., Robert L. Noble, and Charles T. Beer. "Cultured Nb rat lymphoma cells in endocrine and cancer research." Biochemistry and Cell Biology 64, no. 7 (July 1, 1986): 659–66. http://dx.doi.org/10.1139/o86-091.
Full textKumar, Gautam, Ravi Kumar, Girendra Kumar Gautam, and Harshit Rana. "Phytochemical and Pharmacological Properties of Catharanthus roseus (Vinca)." Science Progress and Research 1, no. 4 (October 23, 2021): 429–34. http://dx.doi.org/10.52152/spr/2021.164.
Full textSpagnuolo, Paul A., Jiayi Hu, Rose Hurren, Xiaoming Wang, Marcela Gronda, Mahadeo A. Sukhai, Ashley Di Meo, et al. "The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma." Blood 115, no. 23 (June 10, 2010): 4824–33. http://dx.doi.org/10.1182/blood-2009-09-243055.
Full textKumar, Gautam, Ravi Kumar, Girendra Kumar Gautam, and Harshit Rana. "The phytochemical and pharmacological properties of Catharanthus roseus (Vinca)." Science Progress and Research 2, no. 1 (January 10, 2022): 472–77. http://dx.doi.org/10.52152/spr/2022.158.
Full textBogenberger, James M., Nanna Hansen, Devora Delman, Lisa Sproat, Jeanne Palmer, Ruben Mesa, and Raoul Tibes. "Synergistic Activity of Lysine Deacetylase Inhibitors and Microtubule-Targeting Agents in AML." Blood 128, no. 22 (December 2, 2016): 3948. http://dx.doi.org/10.1182/blood.v128.22.3948.3948.
Full textSpagnuolo, Paul A., Jiayi Hu, Rose Hurren, Ashley Di Meo, Jonathan Boss, Iman Ashali, Marcela Gronda, et al. "The Antihelmintic Flubendazole Inhibits Microtubules through a Mechanism Distinct From Vinca Alkaloids and Displays Preclinical Activity in Leukemia and Myeloma." Blood 114, no. 22 (November 20, 2009): 1017. http://dx.doi.org/10.1182/blood.v114.22.1017.1017.
Full textAhn, Eugene R., John J. Byrnes, Vincenzo Fontana, Pamela Dudkiewicz, Carlos J. Bidot, and Yeon S. Ahn. "Recurrence of Severe ITP Following Administration of G-CSF: Remission Following Platelet and Vinca-Alkaloid Infusion." Blood 110, no. 11 (November 16, 2007): 3222. http://dx.doi.org/10.1182/blood.v110.11.3222.3222.
Full textHarvey, Michael J., Martin G. Banwell, and David W. Lupton. "The synthesis of compounds related to the indole–indoline core of the vinca alkaloids (+)-vinblastine and (+)-vincristine." Tetrahedron Letters 49, no. 32 (August 2008): 4780–83. http://dx.doi.org/10.1016/j.tetlet.2008.05.082.
Full textDragoi, Alexandra, and Oana Alexandru. "PLANT-DERIVED CHEMOTHERAPEUTICS DRUGS FOR CANCER CHEMOTHERAPY." Medico Oncology 1, no. 1 (May 18, 2021): 28–37. http://dx.doi.org/10.52701/monc.2020.v1i1.8.
Full textWillingham, M. C. "Apoptosis And Resistance To Anti-Microtubule Agents." Microscopy and Microanalysis 4, S2 (July 1998): 1036–37. http://dx.doi.org/10.1017/s1431927600025307.
Full textMhaidat, NM, KH Alzoubi, OF Khabour, KZ Alawneh, LA Raffee, ES Alsatari, EI Hussein, and KE Bani-Hani. "Assessment of genotoxicity of vincristine, vinblastine and vinorelbine in human cultured lymphocytes: a comparative study." Balkan Journal of Medical Genetics 19, no. 1 (June 1, 2016): 13–20. http://dx.doi.org/10.1515/bjmg-2016-0002.
Full textMistry, Neelam, Diana Abbott, Japera Walker Wilkison, Ajay Major, Brad M. Haverkos, and Manali Kamdar. "Dose Reduction or Omission of Vinca Alkaloids during Initial Chemotherapy Treatment Does Not Impact Outcomes in Patients with Lymphoma." Blood 134, Supplement_1 (November 13, 2019): 4126. http://dx.doi.org/10.1182/blood-2019-129208.
Full textNagaraja, Padmarajaiah, Ramanathapura A. Vasantha, and Hemmige S. Yathirajan. "Sensitive and Rapid Spectrophotometric Methods for Determination of Anticancer Drugs." Journal of AOAC INTERNATIONAL 85, no. 5 (September 1, 2002): 1021–24. http://dx.doi.org/10.1093/jaoac/85.5.1021.
Full textPrakash, Om, Shazia Usmani, Ruchi Singh, Debarshi K. Mahapatra, and Amresh Gupta. "Cancer Chemotherapy by Novel Bio-active Natural Products: Looking Towards the Future." Current Cancer Therapy Reviews 15, no. 1 (February 22, 2019): 37–49. http://dx.doi.org/10.2174/1573394714666180321151315.
Full textArdeshna, Kirit M., Peter Hoskin, Paul Smith, Nicholas Chadwick, Nivette Braganca, Wai-Lup Wong, Irfan Kayani, et al. "Young Adults Aged 18 to 30 Years with Hodgkin Lymphoma Can Tolerate a Modified Version of the Combined Modality German Paediatric HD95 Protocol with Minimal Neurotoxicity and Excellent Outcome. Results of the UK NCRN 18–30 Study (CRUK/08/012)." Blood 120, no. 21 (November 16, 2012): 1621. http://dx.doi.org/10.1182/blood.v120.21.1621.1621.
Full textCullen, M. H., N. S. Stuart, C. Woodroffe, A. Murphy, J. Fletcher, G. R. Blackledge, J. A. Child, R. J. Grieve, and E. L. Jones. "ChlVPP/PABlOE and radiotherapy in advanced Hodgkin's disease. The Central Lymphoma Group." Journal of Clinical Oncology 12, no. 4 (April 1994): 779–87. http://dx.doi.org/10.1200/jco.1994.12.4.779.
Full textGouazé, Valerie, Jing Y. Yu, Richard J. Bleicher, Tie-Yan Han, Yong-Yu Liu, Hongtao Wang, Michael M. Gottesman, Arie Bitterman, Armando E. Giuliano, and Myles C. Cabot. "Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy." Molecular Cancer Therapeutics 3, no. 5 (May 1, 2004): 633–40. http://dx.doi.org/10.1158/1535-7163.633.3.5.
Full textMitsiades, Constantine S., Cecile Rouleau, Krishna Menon, Beverly Teicher, Massimo Iacobelli, Kenneth C. Anderson, and Paul G. Richardson. "Defibrotide (DF) Targets Tumor-Microenvironmental Interactions and Sensitizes Multiple Myeloma and Solid Tumor Cells to Cytotoxic Chemotherapeutics." Blood 104, no. 11 (November 16, 2004): 286. http://dx.doi.org/10.1182/blood.v104.11.286.286.
Full textBokemeyer, C., C. C. Berger, M. A. Kuczyk, and H. J. Schmoll. "Evaluation of long-term toxicity after chemotherapy for testicular cancer." Journal of Clinical Oncology 14, no. 11 (November 1996): 2923–32. http://dx.doi.org/10.1200/jco.1996.14.11.2923.
Full textEhrhardt, Harald, David Schrembs, Christian Moritz, Franziska Wachter, Subrata Haldar, Ulrike Graubner, Michaela Nathrath, and Irmela Jeremias. "Optimized anti–tumor effects of anthracyclines plus Vinca alkaloids using a novel, mechanism-based application schedule." Blood 118, no. 23 (December 1, 2011): 6123–31. http://dx.doi.org/10.1182/blood-2010-02-269811.
Full textHumbert, Martine, Armelle Goubard, Colin Mansfield, Olivier Hermine, Patrice Dubreuil, and The AB8939 Study Group. "Anticancer Activity of a Highly Potent Small Molecule Tubulin Polymerization Inhibitor, AB8939." Blood 134, Supplement_1 (November 13, 2019): 2075. http://dx.doi.org/10.1182/blood-2019-122540.
Full textVu, Phuong Thi Bach, Dai Minh Cao, Anh Lan Bui, Nhut Nhu Nguyen, Le Van Bui, and Phuong Ngo Diem Quach. "In vitro growth and content of vincristine and vinblastine of Catharanthus roseus L. hairy roots in response to precursors and elicitors." Plant Science Today 9, no. 1 (January 1, 2022): 21–28. http://dx.doi.org/10.14719/pst.1337.
Full textPliankong, Pawnpirun, Padungsak Suksa-Ard, and Surawit Wannakrairoj. "Chitosan Elicitation for Enhancing of Vincristine and Vinblastine Accumulation in Cell Culture of Catharanthus roseus (L.) G. Don." Journal of Agricultural Science 10, no. 12 (November 15, 2018): 287. http://dx.doi.org/10.5539/jas.v10n12p287.
Full textRahmani-Jourdheuil, Dominique, Fabrice Coloma, Michel Placidi, and Roger Rahmani. "Human Hepatic Uptake of Two Vinca Alkaloids: Navelbine and Vincristine." Journal of Pharmaceutical Sciences 83, no. 4 (April 1994): 468–71. http://dx.doi.org/10.1002/jps.2600830404.
Full textRai, Vartika, Pramod Kumar Tandon, and Sayyada Khatoon. "Effect of Chromium on Antioxidant Potential ofCatharanthus roseusVarieties and Production of Their Anticancer Alkaloids: Vincristine and Vinblastine." BioMed Research International 2014 (2014): 1–10. http://dx.doi.org/10.1155/2014/934182.
Full textNaeem, M., Mohd Idrees, Tariq Aftab, M. Masidur Alam, M. Masroor A. Khan, Moin Uddin, and Lalit Varshney. "Radiation Processed Carrageenan Improves Plant Growth, Physiological Activities, and Alkaloids Production in Catharanthus roseus L." Advances in Botany 2015 (January 22, 2015): 1–11. http://dx.doi.org/10.1155/2015/150474.
Full textNapolitano, Andrea, Salvatore Provenzano, Chiara Colombo, Marco Vitellaro, Antonella Brunello, Giuseppe Badalamenti, Margherita Nannini, et al. "Familial adenomatosis polyposis–related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis." ESMO Open 5, no. 1 (January 2020): e000604. http://dx.doi.org/10.1136/esmoopen-2019-000604.
Full textDon, Sima, Nicole M. Verrills, Tracy Y. E. Liaw, Marjorie L. M. Liu, Murray D. Norris, Michelle Haber, and Maria Kavallaris. "Neuronal-associated microtubule proteins class III β-tubulin and MAP2c in neuroblastoma: Role in resistance to microtubule-targeted drugs." Molecular Cancer Therapeutics 3, no. 9 (September 1, 2004): 1137–46. http://dx.doi.org/10.1158/1535-7163.1137.3.9.
Full textNOORMOHAMMADI, ZAHRA, MARYAM TABAN, and FARAH FARAHANI. "Short Communication: The impact of Gamma radiation on Tdc and Str gene expressions in Catharanthus roseus regenerated plantlets." Biodiversitas Journal of Biological Diversity 19, no. 5 (September 21, 2018): 1805–10. http://dx.doi.org/10.13057/biodiv/d190531.
Full textSzabó, Lajos, Hedvig Bölcskei, Baitz-Gács Eszter, Marianna Mák, and Csaba Szántay. "Synthesis of vinca alkaloids and related compounds, Part XCVI[1] Nitration study of vinblastine-type bisindole alkaloids." Archiv der Pharmazie 334, no. 12 (December 2001): 399–405. http://dx.doi.org/10.1002/1521-4184(200112)334:12<399::aid-ardp399>3.0.co;2-1.
Full textHendriks, Hans R., Simon Langdon, Dietmar P. Berger, Knut Breistøl, Heinz H. Fiebig, Øystein Fodstad, and Gilberto Schwartsmann. "Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenografts." European Journal of Cancer 28, no. 4-5 (April 1992): 767–73. http://dx.doi.org/10.1016/0959-8049(92)90112-f.
Full textSzabo, Lajos, Hedvig Boelcskei, Baitz-Gacs Eszter, Marianna Mak, and Csaba Szantay. "ChemInform Abstract: Synthesis of Vinca Alkaloids and Related Compounds. Part 96. Nitration Study of Vinblastine-Type Bisindole Alkaloids." ChemInform 33, no. 18 (May 21, 2010): no. http://dx.doi.org/10.1002/chin.200218202.
Full textBirat, Kanchan, Reem Binsuwaidan, Tariq Omar Siddiqi, Showkat Rasool Mir, Nawaf Alshammari, Mohd Adnan, Rahila Nazir, et al. "Report on Vincristine-Producing Endophytic Fungus Nigrospora zimmermanii from Leaves of Catharanthus roseus." Metabolites 12, no. 11 (November 15, 2022): 1119. http://dx.doi.org/10.3390/metabo12111119.
Full text